Literature DB >> 30260793

Crosstalk between neurokinin receptor signaling and neuroinflammation in neurological disorders.

Prasanth M Eapen1, Chamallamudi Mallikarjuna Rao1, Madhavan Nampoothiri1.   

Abstract

The neurokinin 1 receptor with the natural substrate substance P is one of the intensely studied receptors among the neurokinin receptors. The intracellular signaling mechanism uses G protein-coupled transduction regulating various physiological processes from nausea to Alzheimer's disease. The neurokinin 1 receptor plays a significant role in neuroinflammation-mediated alterations in neural circuitry. Neurokinin 1 receptor antagonists are selective, potent and exhibited efficacy in animal models of nervous system disorders. Evolving data now strengthen the viewpoint of brain substance P/neurokinin 1 receptor axis-mediated action in neural circuit dysfunction. Thus, a deep-rooted analysis of disease mechanism in which the neurokinin 1 receptor is involved is necessary for augmenting disease models which encourage the pharmaceutical industry to intensify the research pipeline. This review is an attempt to outline the concept of neurokinin 1 receptor signaling interlinked to the brain innate immune system. We also uncover the mechanisms of the neurokinin 1 receptor involved in neurological disorder and various methods of modulating the neurokinin 1 receptor, which may result in therapeutic action.

Entities:  

Keywords:  depression; epilepsy; neurodegeneration; neuroinflammation; neurokinin; substance P

Mesh:

Substances:

Year:  2019        PMID: 30260793     DOI: 10.1515/revneuro-2018-0021

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  2 in total

Review 1.  Glial Cell Line-Derived Neurotrophic Factor Family Ligands, Players at the Interface of Neuroinflammation and Neuroprotection: Focus Onto the Glia.

Authors:  Anastasiia Kotliarova; Yulia A Sidorova
Journal:  Front Cell Neurosci       Date:  2021-06-17       Impact factor: 5.505

2.  In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer's disease.

Authors:  Sairaj Satarker; Swastika Maity; Jayesh Mudgal; Madhavan Nampoothiri
Journal:  Mol Divers       Date:  2021-07-31       Impact factor: 2.943

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.